These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4418024)

  • 1. Operation of the "glucose-fatty acid cycle" during experimental elevations of plasma free fatty acid levels in man.
    Balasse EO; Neef MA
    Eur J Clin Invest; 1974 Aug; 4(4):247-52. PubMed ID: 4418024
    [No Abstract]   [Full Text] [Related]  

  • 2. The roles of insulin, glucagon, and free fatty acids in the regulation of ketogenesis in dogs.
    Keller U; Chiasson JL; Liljenquist JE; Cherrington AD; Jennings AS; Crofford OS
    Diabetes; 1977 Nov; 26(11):1040-51. PubMed ID: 913893
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of continuously increasing concentrations of plasma ketone bodies on the uptake and oxidation of glucose by muscle in man.
    Wicklmayr M; Dietze G
    Eur J Clin Invest; 1978 Dec; 8(6):415-21. PubMed ID: 105915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent effect of ketone bodies on forearm glucose metabolism in normal man.
    Walker M; Fulcher GR; Marsiaj H; Orskov H; Alberti KG
    Scand J Clin Lab Invest; 1991 Nov; 51(7):605-13. PubMed ID: 1810020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of free fatty acids and ketone bodies on glucose uptake and oxidation in the dog.
    Balasse EO
    Horm Metab Res; 1971 Nov; 3(6):403-9. PubMed ID: 5131526
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS; Eaton RP
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate utilization by myocardium and skeletal muscle in alloxan-diabetic dogs.
    Wiener R; Spitzer JJ
    Am J Physiol; 1973 Dec; 225(6):1288-94. PubMed ID: 4760442
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of fatty acid metabolism by glucagon in man. IV. Effects of a physiologic hormone infusion in normal man.
    Schade DS; Eaton RP
    Diabetes; 1976 Oct; 25(10):978-83. PubMed ID: 976607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose and free fatty acid utilization in exercise. Studies in normal and diabetic man.
    Wahren J; Hagenfeldt L; Felig P
    Isr J Med Sci; 1975 Jun; 11(6):551-9. PubMed ID: 1099052
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man.
    Krentz AJ; Freedman D; Greene R; McKinley M; Boyle PJ; Schade DS
    Metabolism; 1996 Oct; 45(10):1214-20. PubMed ID: 8843175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of insulin secretion by infusion of free fatty acids.
    Crespin SR; Greenough WB; Steinberg D
    J Clin Invest; 1969 Oct; 48(10):1934-43. PubMed ID: 5822597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caloric homeostasis and disorders of fuel transport.
    Havel RJ
    N Engl J Med; 1972 Dec; 287(23):1186-92. PubMed ID: 4563084
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in the concentrations of glucose, free fatty acids, insulin and ketone bodies in the blood during sodium beta-hydroxybutyrate infusions in man.
    Balasse E; Ooms HA
    Diabetologia; 1968 Jun; 4(3):133-5. PubMed ID: 5738351
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Hydroxybutyrate oxidation is reduced and hepatic balance of ketone bodies and free fatty acids is unaltered in carnitine-depleted, pivalate-treated rats.
    Bianchi PB; Davis AT
    J Nutr; 1996 Nov; 126(11):2867-72. PubMed ID: 8914959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The physiological function of ketone bodies].
    Li YD
    Sheng Li Ke Xue Jin Zhan; 1983 Oct; 14(4):352-5. PubMed ID: 6379873
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.
    Mai K; Bobbert T; Groth C; Assmann A; Meinus S; Kraatz J; Andres J; Arafat AM; Pfeiffer AF; Möhlig M; Spranger J
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E126-30. PubMed ID: 20424140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial concentration and cerebral removal of metabolites in fasting puppies.
    Weng JT; Nakamura Y; Spitzer JJ
    Am J Physiol; 1973 Oct; 225(4):967-71. PubMed ID: 4743386
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketone bodies and the inhibition of free-fatty-acid release.
    Jenkins DJ
    Lancet; 1967 Aug; 2(7511):338-40. PubMed ID: 4143728
    [No Abstract]   [Full Text] [Related]  

  • 19. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of free fatty acids by skeletal muscle during rest and electrical stimulation in control and diabetic dogs.
    Spitzer JJ; Hori S
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):555-9. PubMed ID: 5787138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.